The Biggest Lesson Learned from IBM Watson

There’s no sexier marketing story than IBM Watson. When IBM Watson beat Ken Jennings on Jeopardy, there was an explosion of coverage. The most promising area for IBM Watson was healthcare. However, as the Wall Street Journal recently reported, IBM Watson has fallen short of expectations in healthcare.

More than a dozen IBM partners and clients have halted or shrunk Watson’s oncology-related projects. Watson cancer applications have had limited impact on patients, according to dozens of interviews with medical centers, companies, and doctors who have used it, as well as documents reviewed by The Wall Street Journal.

In many cases, the tools didn’t add much value. In some cases, Watson wasn’t accurate. Watson can be tripped up by a lack of data in rare or recurring cancers, and treatments are evolving faster than Watson’s human trainers can update the system. Dr. Chase of Columbia said he withdrew as an adviser after he grew disappointed in IBM’s direction for marketing the technology.

No published research shows Watson improving patient outcomes.

No doubt, part of the problem is that IBM Watson could never live up to the hype. The hype was too big. However, it seems that IBM Watson has really fallen short from even the most conservative hopes for it. That’s a big problem.

One thing that’s interesting about IBM Watson is that they spent no marketing on it. Especially in healthcare. At the IBM Think events the past couple years they didn’t have any healthcare press or influencers at their event. Their marketing team’s response was that they didn’t have any budget to market to healthcare because they got so much coverage for IBM Watson already.

Fair enough. IBM Watson has gotten a ton of exposure in healthcare, but maybe if they’d invited the press they could have had some real conversations about whether IBM Watson was real or was it memorex (Sorry for those that don’t know this old reference). While not always the case, the healthcare IT press and influencers are a different breed that asks deeper questions about a product and what it can do to impact healthcare. It feels like IBM Watson had so much hype that not enough people held them accountable for actually delivering results to healthcare organizations.

From the same WSJ article linked above is this great quote:

“The discomfort that I have—and that others have had with using it—has been the sense that you never know what you’re really going to get…and how much faith you can put in those results,” said Lukas Wartman of the McDonnell Genome Institute at the Washington University School of Medicine in St. Louis. Dr. Wartman said he rarely uses the system, despite having complimentary access.

The concepts of AI and machine learning that IBM Watson represent are incredible and I believe will impact healthcare for good. However, it’s still not there yet. The trust isn’t there.

The core lesson I take from IBM Watson is that things like Jeopardy can create hype for a certain product, but in healthcare we need more than hype. We need trust. If a healthcare provider can’t trust the result, then your product won’t go anywhere and won’t be used. Unfortunately for IBM Watson, beating Ken Jennings on Jeopardy creates a lot of awareness, but does nothing to build trust.

The jury is still out on IBM Watson on healthcare. They’ve spent billions on it and so it’s not like it’s going to just disappear. Hopefully, it does turn the corner and becomes a trusted tool for many in healthcare. Trust just takes consistency over time. That’s an important lesson for many healthcare IT products.

About the author

John Lynn

John Lynn

John Lynn is the Founder of the HealthcareScene.com, a network of leading Healthcare IT resources. The flagship blog, Healthcare IT Today, contains over 13,000 articles with over half of the articles written by John. These EMR and Healthcare IT related articles have been viewed over 20 million times.

John manages Healthcare IT Central, the leading career Health IT job board. He also organizes the first of its kind conference and community focused on healthcare marketing, Healthcare and IT Marketing Conference, and a healthcare IT conference, EXPO.health, focused on practical healthcare IT innovation. John is an advisor to multiple healthcare IT companies. John is highly involved in social media, and in addition to his blogs can be found on Twitter: @techguy.

1 Comment

Click here to post a comment
   

Categories